Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
1245.65
Change Change %
-7.20 -0.57%

Updated:19 Jun, 2019, 15:59 PM IST

BSE
1243.55
Change Change %
-5.85 -0.47%

Updated:19 Jun, 2019, 16:01 PM IST

Period:

Previous Close
Day's Open
Volume Traded (in 000's)
Value Traded (in Cr)

Day's Range

1236.70 1258.70

52 Wk Range

1236.70 1800.05
Period:

Previous Close
Day's Open
Volume Traded (in 000's)
Value Traded (in Cr)

Day's Range

1235.301250.15

52 Wk Range

1235.30 1812.00

Compare Price performance of vs. Peer Companies

From sector

Compare with Peers on Key Fundamentals and Financials

Color code for Price performance of and Peer companies

  • 5% and above
  • 2% to 5%
  • 0.5% to 2%
  • -0.5% to 0.5%
  • -2% to -0.5%
  • -5% to -2%
  • -5% and below
 

's Latest Research Report

Brokerage/Analyst Report Date Call Price@Call Target Current Status Report
Nomura
-
28-06-2017 Sell 2440.00 2056.00 Target Hit Details

Glaxosmithkline Phar's Key Fundamentals

Parameter Values
Market Cap (in ₹ Cr.) 21,102.06
Earning Per Share (EPS TTM) (₹) 30.34
Price To Earnings (P/E) Ratio 41.06
Book Value Per Share (₹) 126.47
Price To Books (P/B) Ratio 9.85
EBIT Margin (%) 21.23
PAT Margin (%) 13.60
ROCE (%) 31.45
PAT Growth (%) 20.85
Total Debt to Equity (D/E) Ratio 0.00

More from Key Fundamentals »

Glaxosmithkline Phar's Financial Summary

Parameter MAR'18
(₹ Cr.)
MAR'17
(₹ Cr.)
YoY
%Change
Balance Sheet:
Share Capital 84.70 84.70 0.00%
Total Non-Current Liabilities 185.97 184.17 0.98%
Total Current Liabilities 1,596.04 717.46 122.46%
Total Liabilities 3,861.96 2,929.84 31.81%
Total Non-Current Assets 1,698.91 1,280.00 32.73%
Currents Investments 0.00 0.00 0.00%
Cash and Bank 1,279.69 882.23 45.05%
Total Current Assets Excluding Current Investments 2,163.05 1,649.84 31.11%
Total Assets 3,861.96 2,929.84 31.81%
Profit and Loss:
Gross Sales 2,895.88 2,994.51 -3.29%
Net Sales 2,871.69 2,902.99 -1.08%
PBIDT (Excl OI) 508.44 419.93 21.08%
PAT 351.99 336.78 4.52%

More from Financial Summary »

Glaxosmithkline Phar's Shareholding Pattern

..

Post your comments about Glaxosmithkline Phar

Top